News
Comparison of Safety and Efficacy of Oral and Intravenous Administration of Combination NEPA in the Prophylaxis of Chemotherapy-Induced Nausea and Vomiting
Both oral and intravenous administration of a combination of netupitant (a neurokinin 1 receptor antagonist − NK1RA) with palonosetron (a 5-HT3 receptor antagonist) offer prevention of chemotherapy-induced nausea and vomiting (CINV) for up to 5 days after its administration. Although the i.v. form of netupitant (fosnetupitant) + palonosetron (NEPA) did not lead to injection site reactions or anaphylactic reactions in a Phase III study, hypersensitivity and anaphylactic reactions have been described with other i.v. administered NK1RAs. Thus,…
Cost Effectiveness of Netupitant/Palonosetron Combination in the Prophylaxis of Chemotherapy-Induced Nausea and Vomiting
Impact of Oral Antidiabetics on Heart Failure
Position of Levodropropizine in Cough Therapy
Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A
The World of Viruses is Constantly Evolving and Bringing Us New Surprises
Vascular Disease in the Gradually Aging Population of Hemophiliacs: An Underestimated Problem?
Less Ventricular Arrhythmias and ICD Shocks After Introduction of Sacubitril/Valsartan
Diosmin – Still an Important Modality in the Treatment of Venous Insufficiency
Europe and Tooth Decay: The Situation is Improving Thanks to Fluorides and New Technologies
Conferences
News from the world of medicine
All conferences
Popular this week
- Climbing Stairs Helps Prolong Life and Prevent Heart Disease
- A Cap Instead of a Brain Implant?
- Could Artificial Intelligence Help with Emergency Department Triage in the Future?
- Bedřich Smetana’s hearing loss could be caused by chronic mercury intoxication
- BENIGN DERMATOSIS OF PENIS